Michelle McNeal
Family · Frisco, TXNPI 1306383260
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,324 and has fallen 95.1% since, to $113 in 2025.
Across 131 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$463
- Novo Nordisk$227
- Amarin Pharma, Inc.$204
- Lilly USA, LLC$191
- Corcept Therapeutics$161
- Zealand Pharma US, Inc.$133
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,577100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 13 | $463 |
| Novo Nordisk | 7 | $227 |
| Amarin Pharma, Inc. | 15 | $204 |
| Lilly USA, LLC | 15 | $191 |
| Corcept Therapeutics | 4 | $161 |
| Zealand Pharma US, Inc. | 6 | $133 |
| Mannkind Corporation | 9 | $123 |
| Abbott | 8 | $115 |
| Sanofi-aventis U.S. LLC | 7 | $115 |
| Clarus Therapeutics Inc. | 7 | $107 |
| Boehringer Ingelheim | 6 | $98 |
| Antares Pharma, Inc. | 5 | $96 |
| Esperion Therapeutics, Inc. | 4 | $92 |
| Amgen | 3 | $57 |
| Insulet Corporation | 2 | $43 |
| Cequr Corporation | 1 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $36 |
| Alfasigma USA, Inc. | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| AbbVie | 2 | $34 |
| IBSA Pharma Inc. | 2 | $26 |
| Medtronic | 1 | $20 |
| BD | 1 | $20 |
| Ascensia Diabetes Care US Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Radius Health, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,577 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Frisco
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.